Celldex Therapeutics Inc (CLDX)
CapEx to Revenue
14450.00%
Quarterly · Period ending:
CLDX CapEx to Revenue
Latest reported14450.00%period ending
Latest reported14450.00%period ending
CLDX Quarterly CapEx/Revenue (0.00% → 14450.00%)
Latest values, visible window
High-resolution chart · PNG
CLDX capex to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | CapEx to Revenue |
|---|---|
| 14,450% | |
| 10,926.6667% | |
| 1,324% | |
| 0% | |
| 99.726% | |
| 38.1295% | |
| 64.3404% | |
| 19.367% | |
| 10.9688% | |
| 220.5128% | |
| 16.122% | |
| 10.3494% | |
| 152.9851% | |
| 60.4964% | |
| 14.5691% | |
| 84.7666% | |
| 412.8834% | |
| 330.4598% | |
| 105.988% | |
| 120.915% | |
| 4.1092% | |
| 82.7737% | |
| 6.5258% | |
| 23.9521% | |
| 385.5932% | |
| 8.6144% | |
| 11.8377% | |
| 26.0073% | |
| 41.6783% | |
| 13.0526% | |
| 9.1837% | |
| 6.3762% | |
| 12.0159% | |
| 6.3668% | |
| 5.4977% | |
| 7.1865% | |
| 24.6017% | |
| 24.3807% | |
| 34.0448% | |
| 36.3063% | |
| 55.2196% | |
| 41.4428% | |
| 22.7374% | |
| 132.6511% | |
| 71.0285% | |
| 321.1934% | |
| 11.0359% | |
| 61.0354% | |
| 151.8581% | |
| 46.875% | |
| 373.871% | |
| 100.4082% | |
| 778.3505% | |
| 6.7109% | |
| 3.0162% | |
| 2.2808% | |
| 3.9821% | |
| 1.7263% | |
| 4.355% | |
| 5.1206% | |
| 4.0984% | |
| 8.0286% | |
| 1.1612% | |
| 22.1346% | |
| 25.2457% | |
| 10.342% | |
| 1.8593% | |
| 2.8536% | |
| 6.8782% | |
| 3.7603% | |
| 0.8951% | |
| 37.3582% | |
| 19.6014% | |
| 8.4791% | |
| 33.598% | |
| 364.6944% | |
| 140.7999% | |
| 168.8242% | |
| 992.9945% | |
| 848.7776% | |
| 393.3301% | |
| 18.4648% | |
| 213.0254% | |
| 63.6011% | |
| 71.1352% | |
| 37.0631% | |
| 64.7115% | |
| 219.257% | |
| 17.5476% | |
| 8.0608% | |
| 4.9318% | |
| 0.4913% | |
| 5.332% | |
| 14.7279% | |
| 21.67% | |
| 1.1117% | |
| 24.2844% | |
| 26.8056% | |
| 15.9132% | |
| 0% |